A comparison of surgical resection and radiofrequency ablation for the treatment of single small hepatocellular carcinoma ≤2 cm

Hepatology

Volumn 59, Issue 4, 2014, Pages 1653-1653

  Cho, Yun Ku ^a  

^a Veterans Health Service Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

BILIRUBIN BLOOD LEVEL; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; HUMAN; HYPERBILIRUBINEMIA; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PORTAL HYPERTENSION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SINGLE SMALL HEPATOCELLULAR CARCINOMA; SURVIVAL RATE;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE;

EID: 84896488356     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26692     Document Type: Letter

References (4)

1. Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A, et al. Resection of hepatocellular cancer
2. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008;47:82-89.
3. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
4. Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010;51:1284-1290.